A randomized pilot study of dietary treatments for polycystic ovary syndrome in adolescents

被引:36
|
作者
Wong, J. M. W. [1 ,2 ]
Gallagher, M. [1 ]
Gooding, H. [3 ]
Feldman, H. A. [4 ]
Gordon, C. M. [5 ,6 ]
Ludwig, D. S. [1 ]
Ebbeling, C. B. [1 ]
机构
[1] Boston Childrens Hosp, New Balance Fdn, Obes Prevent Ctr, 300 Longwood Ave AU307, Boston, MA 02115 USA
[2] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada
[3] Boston Childrens Hosp, Div Adolescent & Young Adult Med, Boston, MA USA
[4] Boston Childrens Hosp, Clin Res Ctr, Boston, MA USA
[5] Hasbro Childrens Hosp, Div Adolescent Med, Providence, RI USA
[6] Hasbro Childrens Hosp, Div Endocrinol, Providence, RI USA
来源
PEDIATRIC OBESITY | 2016年 / 11卷 / 03期
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
Bioavailable testosterone; dietary intervention; electronic medical record; polycystic ovary syndrome; LIFE-STYLE INTERVENTION; WEIGHT-LOSS; CARDIOVASCULAR RISK; METABOLIC SYNDROME; ANDROGEN EXCESS; WOMEN; OBESITY; GIRLS; ENDOCRINE; METFORMIN;
D O I
10.1111/ijpo.12047
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Evidence is lacking to recommend one diet over another when treating polycystic ovary syndrome (PCOS). Objectives: To obtain preliminary data, comparing the impact of a low-glycaemic load (LGL) vs. low-fat (LF) diet on biochemical hyperandrogenism in overweight and obese adolescents with PCOS. To ascertain feasibility of recruiting study participants, in partnership with an adolescent clinic, and implementing dietary interventions. Methods: Randomized controlled trial of 19 overweight and obese adolescents with PCOS and not using hormonal contraceptives (HCs). Interventions comprised nutrition education, dietary counselling and cooking workshops to foster adherence to a LGL (45% carbohydrate, 35% fat, 20% protein) or LF (55% carbohydrate, 25% fat, 20% protein) diet over 6 months. Serum bioavailable testosterone was the primary outcome. Results: Sixteen (LGL, n = 7; LF, n = 9) participants completed the study. Body fat percentage decreased (P < 0.05) in response to the interventions, with no difference between the LGL and LF groups (-1.2% vs. -2.2%; P = 0.16). Bioavailable testosterone did not change for either group (-0.4 vs. -1.8 ng dL(-1); P = 0.35). Regarding feasibility, recruiting adolescents posed a challenge, and use of HCs was a main reason for ineligibility. Participants attended 5.9 of 6 in-person visits and 2.6 of 3 cooking workshops, completed 4.9 of 6 telephone counselling calls, and reported high satisfaction with the diets and cooking workshops (>= 8 on a 10-cm scale). Conclusions: Dietary interventions were beneficial for weight control but did not attenuate biochemical hyperandrogenism. Innovative strategies are needed to recruit adolescents for studies aimed at assessing independent effects of diet on features of PCOS.
引用
收藏
页码:210 / 220
页数:11
相关论文
共 50 条
  • [31] Metformin for adolescents with polycystic ovary syndrome
    Ying-hua LIU
    Li-hui HOU
    Yan LI
    Ming LIU
    Fang XU
    Ying WANG
    Journal of Reproduction and Contraception, 2015, (02) : 103 - 111
  • [32] The Diagnosis of Polycystic Ovary Syndrome in Adolescents
    Rosenfield, Robert L.
    PEDIATRICS, 2015, 136 (06) : 1154 - 1165
  • [33] Polycystic ovary syndrome in obese adolescents
    Stanley, Takara
    Misra, Madhusmita
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2008, 15 (01) : 30 - 36
  • [34] Polycystic ovary syndrome in adolescents with obesity
    Fu, Leyi
    Qu, Fan
    Pan, Jiexue
    Wang, Tian
    Wang, Fangfang
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (03): : 468 - 473
  • [35] Gut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments
    Garcia-Beltran, Cristina
    Malpique, Rita
    Carbonetto, Belen
    Gonzalez-Torres, Pedro
    Henares, Desiree
    Brotons, Pedro
    Munoz-Almagro, Carmen
    Lopez-Bermejo, Abel
    de Zegher, Francis
    Ibanez, Lourdes
    PEDIATRIC OBESITY, 2021, 16 (04):
  • [37] Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
    Atiomo, W.
    Daykin, C. A.
    MOLECULAR HUMAN REPRODUCTION, 2012, 18 (11) : 546 - 553
  • [38] Bisphenol A in patients with polycystic ovary syndrome, a pilot study.
    Hamat, I. C.
    Frigo, P.
    Decker, G.
    Schneeberger, C.
    Huber, J. C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2010, 70 (05) : 429 - 430
  • [39] POLYCYSTIC OVARY SYNDROME RISK ALGORITHM (PRISKA): A PILOT STUDY
    Van Der Ham, Kim
    Sillman, Johanna
    Hund, Martin
    Mang, Anika
    Louwers, Yvonne V.
    Laven, Joop S. E.
    FERTILITY AND STERILITY, 2024, 122 (04) : E384 - E384
  • [40] Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women
    Shi, Yuhua
    Gao, Xuan
    Sun, Xuedong
    Zhang, Peng
    Chen, Zijiang
    FERTILITY AND STERILITY, 2008, 90 (04) : 1139 - 1143